Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

LIVN

+ Watchlist+ Portfolio

LivaNova PLC

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$91.92
52-Week Range
$53.37 – $99.38
Market Cap
$5.21B
P/E (TTM)
27.09
EPS (TTM)
3.49
Dividend Yield
0.00%
Advanced Metrics
Price/Book
3.80
PEG Ratio
0.93
Return on Equity
15.50%
Return on Assets
5.11%
Gross Margin
67.64%
Operating Margin
14.30%
Profit Margin
13.01%
Current Ratio
1.46
Debt/Equity
0.26
Total Debt
$357.07M
Free Cash Flow
$67.71M
Revenue Growth
9.90%
Earnings Growth
-78.20%
Enterprise Value
$5.00B

Market Snapshot

About

LivaNova PLC is a global medical technology company focused on cardiovascular and neuromodulation solutions. The company develops and manufactures products for cardiac surgery, including heart-lung machines and oxygenators, as well as neuromodulation devices for epilepsy and treatment-resistant depression. LivaNova's product portfolio spans cardiac rhythm management, cardiac surgery, and advanced circulatory support technologies. The company serves healthcare providers worldwide with innovative medical devices and patient monitoring systems.